2B77:XETRA:XETRA-iShares Ageing Population UCITS Acc (EUR)

ETF | Others |

Last Closing

USD 7.491

Change

+0.05 (+0.63)%

Market Cap

USD 0.50B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.05 (-0.09%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.14%)

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.10 (-0.34%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.07 (-0.26%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.08 (+0.30%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.04%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

-0.82 (-0.59%)

USD 102.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.10 (-0.19%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.33 (+0.31%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.92 (+0.15%)

USD 80.38B

ETFs Containing 2B77:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.67% 81% B- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.67% 81% B- 77% C+
Trailing 12 Months  
Capital Gain 19.63% 67% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.63% 66% D+ 67% D+
Trailing 5 Years  
Capital Gain 29.09% 57% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.09% 53% F 55% F
Average Annual (5 Year Horizon)  
Capital Gain 8.59% 59% D- 59% D-
Dividend Return 8.59% 58% F 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.73% 32% F 44% F
Risk Adjusted Return 54.60% 47% F 53% F
Market Capitalization 0.50B 66% D+ 58% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.